Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Journal:Journal of Hepatology | 2022 | ||
ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH Proceeding/Conference:Journal of Hepatology | 2021 | ||
Living in the nonâalcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives Journal:Alimentary Pharmacology & Therapeutics | 2022 | ||
Risk assessment with gut microbiome and metabolite markers in NAFLD development Journal:Science Translational Medicine | 8-Jun-2022 |